Hebei Aoxing Group Pharmaceutical Co.,Ltd

Shijiazhuang, Hebei, China

• MOQ 5000 Piece(s)
• Brand NameAoxing
• 0.28gBlister pack.PVC,12 capsules/piece
• Country of OriginChina
• hard capsulebrown-yellow powder
• Model Number Z13021496

Ingredients: Sanqi tofal Saponins, Gastrodin, Jiangcan, White monkshood, Fangfeng, Notopterygium, Araceae, Angelica dahurica. Properties: The products are hard capsules, it contains brown-yellow powder, it smells fragrant and tastes spicy and hot. Indications: The product facilitates expectoration and expells wind. It relieves pain, phlegm and blood stasis and toothache, sore throat, oral ulcers, osteoarthrosis, phlegm and blood stasis caused by cold. The symptoms includes: joint swelling, muscular constricture. It is also used for the assistance of tetanus. Specification: 0.28g/capsule. Dosage and usage: Take two capsules orally three times a day, Chindren reduce the amount according the actual situation. For external application: clean the wound with saline, spread the powder in the capsule on the affected area, or mix it with sesame oil, then apply it to the affected area. Precautions: For women in pregnancy, the drug should be used with caution. Storage&Package: Sealed and stored. Blister pack.PVC, 12 capsules/piece, 3 pieces/carton Executive Standard: State Food and Drug Administration standard WS3-B-3872-98-2005 Registered number of approval: SFDA approval number Z13021496

• MOQ 200 Piece(s)
• Brand NameAoxing
• Composite film bag. Each bag contains 10mgbrown-colored granules
• Model NumberZ13022534
• Country of OriginChina

Ingredients: Ginseng, Ophiopogon, Schisandra, Astragalus, Angelica, longan meat, cinnamon, Ganoderma lucidum, Millettia, poria, hawthorn, red sage root, spine date seed , donkey-hide gelatin, The auxilarly material is sugar. Properties: The product is brown-colored granules. It tastes sweet and a little bitter. It has faint odor Indications: The product is used for benefiting qi for activating blood circulation, nourishing blood for tranquillization, palpitation and short of breath because of hard work. It is also used for pain of limbs, general weakness, mental fatigue, irritability, insomnia, loss of appetite and physical weakness after illness. Specification: Each bag contains 10mg( equivalent to 13.2 mg to the original medicine) Dosae and usage: Take the drug with boiled water, 10-20mg each time, once to three times a day, one course of treatment is made up of 6 days. Storage: It should be sealed. Package: Composite film bag. Each bag contains 10mg. Each box contains 10 bags. Validity: 24 months. Executive Standard: The standard issued Ministry of Health for Chinese medicine formulations.WS3-B-2979-98 Registered number of approval: SFDA approval number Z13022534.

• MOQ 240 Pack(s)
• 5ml,2.2%(calculation based on Bismuth)With special aromatic
• Oral Liquidyellowish transparent liquid

Items: Bismuth Potassium Citrate Oral Solution Ingredients: This product is containing bismuth 110g/Pcs.The accessories are dementholized peppermint oil, Steviosin, ethylparaben Properties: It is colorless or yellowish transparent liquid. With special aromatic gas, tastes sweet Indications: It's Used for chronic gestritis and alleviating stomach acid which cause stomach pain, stomach burnning(heartburn) and reversing acid Specifications: 2.2%(calculation based on Bismuth) Dosage and usage: one piece (5ml) per time, taken orally with warm boiled water diluted to 3 times of the drug, 3 times a day Storage: Stored in shady and cool place(not more than 20 °C). Package: PVC/PE PDC, 5ml/pc, 6pcs/box Validity: 24 months Executive Standard: Chemical medicine: Regional standards lifted to national standards, (Book II of The National Drug Standards) WS-10001-(HD-0127)-2002 Registered number of approval: Chinese Drug Approval Number H13023305

• white tabletsoff-white tablets
• 10 tablets/plate, 1 plate/boxEach tablet contains 500mg acetaminophen and 65mg caffeine

• MOQ 500 Pack(s)
• Injectioncolorless and transparent liquid

Properties: This product is a colorless and transparent liquid. Indications: This product is opioid receptor antagonist. 1. It is indicated to treat the symptom of post Opioids for post-anesthesia, antagonize such drug-induced respiratory depression and bring the patients to themselves. 2. It is used for over opioid overdose, complete or reverse opiod-induced respiratory depression. 3. It is used to treat acute alcohol poisoning. 4. It is used for the diagnosis of over opioid overdose Speciations: (1)1ml: 1mg Usage and dosage: As a result of obvious individual differences for the product, it is suggested that the application should be based on the specific circustances of the patients and whether the patients should require the product by doctors. The injection is administered by intravenous or intramuscular injection, intravenous injection pvovides a quick effect and suitable for use in emergency. Because the effect of opioid may exceed the duration of the injection, the patient should be in constant ward, if necessary, the injection can be used again and again. Intravenous injection: The injection canbe diluted by saline or glucose solution, add the injection 2mg to500ml either kind of the liquids, so that the concentration can reach 0.004mg/ml, the mixture should be used within 24 hours, more than 24 hours, if it remains unused, then the mixture must be discarded. The speed of Drip should be under control of according to the patient, s response.

• MOQ 600 Pack(s)
• Injections2ml:50mg

Item: The drugs for cerebral thrombosis Indications: For ischemic cerebrovascular diseases(such as cerebral ischemia, cerebral thrombosis, cerebral infarction, etc.) Dosage and usage: Intravenous drip. 50-100mg each time, diluted in 5% -10% glucose injection liquid or sodium chloride injection 250-500ml, slowly drip, Finsih driping within 3-4 hours, once a day over 10-15 days, as one course of treatment or prescribed. Storage: The product should be protected against exposure to light and be confined in the container. Executive Standard: State Food and Drug Administration standard YBH0652008 Registered number of approval: SFDA approval number H20083530